SCHEMBL11083231

SCHEMBL11083231

NCC(CN)c1cc(Br)cc(Br)c1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.37
IDO1 P14902 2/20 0.35
TDO2 P48775 1/20 0.35
GABBR2 O75899 1/20 0.30
GABBR1 Q9UBS5 1/20 0.30
TACR1 P25103 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11084940 0.81 SLC6A2 (0.33)
SCHEMBL11078413 0.77 IDO1 (0.52) HTR2AIDO1TDO2GABBR2GABBR1
SCHEMBL4158091 0.75 TAAR1 (0.48) HTR2AIDO1
SCHEMBL7148283 0.75 BLM (0.47)
SCHEMBL15805898 0.74 IDO1 (0.35) HTR2AIDO1TDO2
SCHEMBL11079558 0.74 HTR2A (0.58) HTR2AGABBR2GABBR1
Hydrochloric Acid SCHEMBL1866896 0.72 HTR2A (0.56) HTR2AIDO1GABBR2GABBR1
SCHEMBL11078097 0.70 ALDH1A1 (0.37)
SCHEMBL13995278 0.70 HTR2A (0.30) HTR2A
SCHEMBL16169725 0.69 SLC6A2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0024776-B1 4-PHENYL AND 5-PHENYL-1,4,5,6-TETRAHYDROPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES, AND PROCESS FOR PREPARING SAID DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1984-12-27 EP disclosed
US-4322421-A 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydro-pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1982-03-30 US disclosed
US-4261995-A DISORDERS OF CENTRAL NERVOUS SYSTEM AND CARDIOVASCULAR SYSTEM; HYPOTENSIVE SYNTEX (U.S.A.) INC. (US) 1981-04-14 US disclosed
EP-0024776-A1 4-Phenyl and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives, pharmaceutical compositions containing said derivatives, and process for preparing said derivatives SYNTEX (U.S.A.) INC. (US) 1981-03-11 EP disclosed